Cavitation-Free Acoustic Sensitization Enhances PLK4-Targeted Therapy Using the Phillyrin Derivative DE02 in Osteosarcoma.

Yang J, Wang H, He Z, Wang W, Qian J.

Open source

DOI
10.1177/10849785261446291
Published
2026-05-07
Container
Cancer Biother Radiopharm
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10849785261446291,
  title = {Cavitation-Free Acoustic Sensitization Enhances PLK4-Targeted Therapy Using the Phillyrin Derivative DE02 in Osteosarcoma.},
  author = {Yang J and  Wang H and  He Z and  Wang W and  Qian J.},
  year = {2026},
  journal = {Cancer Biother Radiopharm},
  doi = {10.1177/10849785261446291},
  url = {https://doi.org/10.1177/10849785261446291}
}

RIS

TY  - JOUR
TI  - Cavitation-Free Acoustic Sensitization Enhances PLK4-Targeted Therapy Using the Phillyrin Derivative DE02 in Osteosarcoma.
AU  - Yang J
AU  -  Wang H
AU  -  He Z
AU  -  Wang W
AU  -  Qian J.
PY  - 2026
JO  - Cancer Biother Radiopharm
DO  - 10.1177/10849785261446291
UR  - https://doi.org/10.1177/10849785261446291
ER  - 

APA

J, Y., H, W., Z, H., W, W., & J., Q. (2026). Cavitation-Free Acoustic Sensitization Enhances PLK4-Targeted Therapy Using the Phillyrin Derivative DE02 in Osteosarcoma.. Cancer Biother Radiopharm. https://doi.org/10.1177/10849785261446291

Source records